Evidence map›Paper›PMID 28587468›Full record

ArticleJournal of proteome research2017

Human Platelet Vesicles Exhibit Distinct Size and Proteome.

Bhanu P Jena, Paul M Stemmer, Sunxi Wang, Guangzhao Mao, Kenneth T Lewis, Daniel A Walz

Abstract read
In one paragraph

Article in Journal of proteome research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Exosome-enriched fractions from MS B cells induce oligodendrocyte death.Neurology(R) neuroimmunology & neuroinflammation · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Bhanu P JenaDepartment of Physiology, School of Medicine, ‡Department of Chemical Engineering & Materials Science, College of Engineering, and §Institute of Environment Health Sciences, Wayne State University , Detroit, Michigan 48201, United States.ORCID 0000-0002-6030-8766
Paul M StemmerDepartment of Physiology, School of Medicine, ‡Department of Chemical Engineering & Materials Science, College of Engineering, and §Institute of Environment Health Sciences, Wayne State University , Detroit, Michigan 48201, United States.ORCID 0000-0003-3315-9846
Sunxi WangDepartment of Physiology, School of Medicine, ‡Department of Chemical Engineering & Materials Science, College of Engineering, and §Institute of Environment Health Sciences, Wayne State University , Detroit, Michigan 48201, United States.
Guangzhao MaoDepartment of Physiology, School of Medicine, ‡Department of Chemical Engineering & Materials Science, College of Engineering, and §Institute of Environment Health Sciences, Wayne State University , Detroit, Michigan 48201, United States.
Kenneth T LewisDepartment of Physiology, School of Medicine, ‡Department of Chemical Engineering & Materials Science, College of Engineering, and §Institute of Environment Health Sciences, Wayne State University , Detroit, Michigan 48201, United States.
Daniel A WalzDepartment of Physiology, School of Medicine, ‡Department of Chemical Engineering & Materials Science, College of Engineering, and §Institute of Environment Health Sciences, Wayne State University , Detroit, Michigan 48201, United States.
Wayne State University · US

Funding

Tumor Biology and Microenvironment (Program 1)P30CA022453 · NCI · WAYNE STATE UNIVERSITY · PI Julie Lynn Boerner · 1985 to 2026
$68.4M
Pilot Project ProgramP30ES020957 · NIEHS · WAYNE STATE UNIVERSITY · PI RUDEN, DOUGLAS M · 2014 to 2021
$10.1M
UNDERSTANDING MEMBRANE FUSION A BIOENGINEERING APPROACHR01EB000303 · NIBIB · WAYNE STATE UNIVERSITY · PI JENA, BHANU P · 2002 to 2004
$1.2M
Orbitrap Velos with ETD for Wayne State ProteomicsS10OD010700 · OD · WAYNE STATE UNIVERSITY · PI STEMMER, PAUL M · 2012 to 2012
$575k
NCI NIH HHS P30 CA022453NIBIB NIH HHS R01 EB000303NIEHS NIH HHS P30 ES020957NIH HHS S10 OD010700
6 · The paper itself

Abstract

In the past 50 years, isolated blood platelets have had restricted use in wound healing, cancer therapy, and organ and tissue transplant, to name a few. The major obstacle for its unrestricted use has been, among others, the presence of ultrahigh concentrations of growth factors and the presence of both pro-angiogenic and anti-angiogenic proteins. To overcome this problem requires the isolation and separation of the membrane bound secretory vesicles containing the different factors. In the current study, high-resolution imaging of isolated secretory vesicles from human platelets using atomic force microscopy (AFM) and mass spectrometry enabled characterization of the remaining vesicles size and composition following their immunoseparation. The remaining vesicles obtained following osmotic lysis, when subjected to immunoseparation employing antibody to different vesicle-associated membrane proteins (VAMPs), demonstrate for the first time that VAMP-3-, VAMP-7-, and VAMP-8-specific vesicles each possesses distinct size range and composition. These results provide a window into our understanding of the heterogeneous population of vesicles in human platelets and their stability following both physical manipulation using AFM and osmotic lysis of the platelet. This study further provides a platform for isolation and the detailed characterization of platelet granules, with promise for their future use in therapy. Additionally, results from the study demonstrate that secretory vesicles of different size found in cells reflect their unique and specialized composition and function.

Indexed as

Blood PlateletsCells, CulturedChemical FractionationHumansImmunoprecipitationMicroscopy, Atomic ForceMolecular Sequence AnnotationOsmotic PressureProteomeR-SNARE ProteinsSecretory VesiclesSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationVesicle-Associated Membrane Protein 3ProteomeR-SNARE ProteinsVAMP3 protein, humanVAMP7 protein, humanVAMP8 protein, humanVesicle-Associated Membrane Protein 3atomic force microscopyhuman platelet vesicle proteometandem mass spectrometry

Identifiers

PMID28587468
PMCPMC6844074
OpenAlexW2621533938

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.